Autoantibodies to lymphocytes have been detected in sera from human immunodeficiency virus type 1 (HIV-l)-infected individuals, and several autoantigens have been described. Among them, hyposialylated CD43 has been shown to be a target for autoantibodies in up to 47% of HIV+ individuals. However, the corresponding autoantigen (ie, the incompletely sialylated CD43) has not been isolated from blood cells of HIV-l-infected individuals. Recently, we have observed in vitro that HIV-1 productively or latently infected CEM cells (CEMmI/NP) express CD43 molecules with modified glycosylation (mogly CD43). Using CEMul/NP cells, which do not express any structural viral antigen, we show now that all of the tested HIV' sera from asymptomatic ESPITE THE DEMONSTRATION of active and progressive infection in human immunodeficiency virus type l (HIV-])-infected individuals during the prolonged, clinically asymptomatic stage of the illness,',2 pathogenesis of acquired immunodeficiency syndrome (AIDS) is thought to involve several factors rather than only a CD4' T-cell destruction monitored by the virus.'-5 Among different pathogenic mechanisms is autoimmunity,6 which has been found to be directed against lymphocyte^,^"^ platelet^,'^.'^ and peripheral nerve^.'^,^' Several candidate autoantigens have been proposed, including a protein of 18 kD expressed in stimulated (but not in resting) lymphocytes,I8 major histocornpatability complex class TI antigens," soluble, recombinant forms of CD4," GM3 lymphocytic ganglioside,*' and nucleosomes.22
individuals, and up to 86% of those from subjects at the acquired immunodeficiency syndrome stage contain antibodies (mainly IgM and, to a lesser degree, IgG) that recognize the surface of CEMW/NP cells, and precipitate mogly CD43 molecules from the cells lysates. Taken together with our previous demonstration of altered glycosylation of CD43 from HIV-l-infected CEM cells in vitro, the constant antimogly CD43 autoimmune response observed from asymptomatic HIV-I+ subjects is likely to illustrate the occurence of an altered glycosylation in vivo of the major lymphocyte surface CD43 glycoprotein, associated with HIV-1 infection. 0 1995 by The American Society of Hematology.
phocytes from HIV-l-infected individuals, the mechanism proposed by the authors to explain this very specific autoimmune response was exposure of autoimmunogenic CD43 epitopes caused by an increased lymphocyte destruction in HIV-1' subjects.
Recently, we showed dramatic alterations (hyposialylation and changed substitution on N-acetylgalactosamine [GalNAc] residues) in CD43 glycosylation status in latently or virus-producing HIV-l-infected T lymphocytes of the CEM cell line.25 These data indicate that the modified CD43 molecules (mogly CD43) can explain, at least in part, the anti-CD43 autoimmune response.
CD43 is the major integral membrane glycoprotein of the It is also expressed on the surface of all the nucleated cells of haematopoietic origin." This protein participates in monocyte and T-lymphocyte activation as an accessory signaling/activation m~l e c u l e ,~~~" and regulates lymphocyte adhe~ion.~' Moreover, it has been shown that this molecule is defective in the congenital immunodeficiency Wiskott-Aldrich ~yndrome.'~.'~ Using a sensitive metabolic sulforadiolabeling assay, 35 we show here that these modified CD43 molecules we described in HIV-l-infected CEM cells2' are precipitated by sera from all the asymptomatic HIV-1 + individuals.
MATERIALS AND METHODS

Sera and antibodies. Sera from rheumatoid arthritis (n = 15).
chronic B hepatitis (n = 22), and systemic lupus erythematosus (n This antiserum showed a 110-to 120-kD band in Westem-blotting assay against a lysate from parental CEM cells and a broad 130-to 170-kD band from CEMLAt/NP cells (not shown) corresponding to the sialylated and partially sialylated forms of CD43, respectively?' The anti-HIV gp160/120 was the RL16.76.1 MoAb (purchased from Immunotech SA, Marseille, France).
Sucrose density gradient fractionation of human Ig. Total IgM and IgG were fractionated from whole human sera by ultracentrifugation, according to a published procedure?' with modifications. Density gradients were prepared in 13.2-mL cellulose nitrate tubes by layering three different sucrose solutions in PBS (40%, 25%, and 10% [wt/vol], 4 mL of each) which were equilibrated by standing at 4°C for 18 hours. Then, 1 mL of human serum diluted 1 5 in PBS was carefully laid on top of the gradient and centrifuged at 150,000g for 18 hours in a SW41 swinging bucket rotor. Thereafter, 0.3-mL fractions were collected at the bottom of the tube, dialyzed on a SpectraPor Microdialyser (Spectrum, Houston, TX), and selected as containing only IgM or IgG by a sensitive radial immunodiffusion test (LC-Partigen purchased from Behring Diagnostic). The reactivity of fractionated Ig was next tested in an indirect immunofluorescence assay, using biotin-labeled antihuman Ig rabbit sera, specific for p or y chain, as described below.
Cells, cultures, and HIV-I strains. Human peripheral blood lymphomonocytes (PBMCs) were separated from total blood, stimulated by 1 pg/mL PHA-L (Boehringer Mannheim GmbH Biochemica, Mannheim, Germany) for 3 days, washed, and thereafter resuspended in RPMI 1640 medium (GIBCO Laboratories Life Technologies, Inc, Grand Island, NY) containing 20% fetal calf serum (FCS; Whittaker MA Bioproducts, Inc, Walkersville, MD) and 20 U/mL interleukin-2 (Boehringer Mannheim). mmom NaCI, 10 mmol/L EDTA, 1 m m o a EGTA, 1 mmoVL phenylmethylsulfonyl (PMSF; Sigma), 10 mg/mL aprotinin (Sigma), and 10 m@mL leupeptin (Boehringer Mannheim). After centrifugation of the lysates ( l 8,000g for l hour), 50-pL aliquots of the different human Ig (corresponding to 100 pL of undiluted serum) were added to supematants. After shaking for 1 hour at 4"C, 25 pL protein A-sepharose 4B beads (Sigma) precoated with 10 pL of rabbit antihuman Ig serum were added. In other experiments, CD43 was also precipitated by the following specific antibodies: LeukC antiserum (10 pL of the rabbit serum precoated on protein A-sepharose 4B beads) or CD43 IgGl MoAb (2 pg attached to beads precoated with 10 pL rabbit antimouse Ig serum). After shaking for 2 hours, precipitates were collected by brief centrifugation. Where indicated, to sort various CD43 species according to their different glycosylation status, immunoprecipitated molecules were eluted by boiling the coated beads in 50 pL lysis buffer containing 1 % sodium dodecyl sulfate (SDS) for 3 minutes. Then, supernatants were separated, and diluted 20-fold in lysis-buffer, before reincubating with PNA or SNA (from Sambucus nigra) immobilized lectins (EY Laboratories), by shaking for 1 hour at 4°C. Finally, the pellets were washed 3 times in lysis-buffer and once with the same buffer containing 1 m o a NaCI. They were resuspended in sample buffer (2% SDS, 1.7 moU L 2-mercaptoethanol [2-ME]) and boiled for 3 minutes. Samples were resolved by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) (7.5% gels). Molecular mass markers (GIBCO-BRL) were heavy (H)-chain Myosin (206.5 kD) and phosphorylase B (105.1 kD). After intensification with Amplify (Amersham, Arlington Heights, IL), the gels were vacuum-dried and exposed to XAR5 Kodak films (Eastman Kodak, Rochester, NY). and finally stopped. The latently-infected CEMLAI/NP cells were positive for the presence of HIV-1 provirus.39 These cells are stably virus nonproducing. They are negative for HIV-1 ~2 4~'~ antigen." To confirm that they do not express any viral antigen at the cell surface, an additional control was performed with anti-HIV-l""' MoAb that was unable to show any antigen at the surface of CEMLAI/NP cells (not shown). Although IUdR inductions were able to reactivate these cells, which then become virus producing for a 5-to 6-day period (not shown) as described by others,43 they did not express any capsid nor envelop viral antigen nor reversetranscriptase activity. No HIV transcript was shown by Northern blot analysis (not shown). To characterize the frequency of provirus persistence, 48 subclones obtained by limiting dilution from CEMLAINP cells were screened for the presence of HIV-1 sequences by polymerase chain reaction (PCR), using the P3-P4 and SK68-SK69 primers sets, overlapping the Pol and Env genes, re~pectively.""~ When probing the PCR products with P5 and SK70 oligonucleotides, it was observed that six subclones were positive for one or two primers sets (not shown), thus showing that at least 12% of cells harbored some HIV-1 sequences.
RESULTS
CEM,,RVP cells are latently HIV-I-infected, virus-nonproducing cells. As we described earlier,39 the CEMLAI/NP cell line was obtained after infection of CEM cells by the HIV-1 LA1 (BRU) strain. Virus production was observed for approximately 6 months, then progressively decreased
CEM,,ATP cells are stained by antibodies obtained from H N -I + human sera. We have shown that HIV-l -infected CEMLAI/NP cells that do not express any viral antigen" synthesize CD43 molecules having a modified glycosylation (mogly CD43). This leads to exposure of galactose-N-acetylgalactosamine (Gal-GalNAc) disaccharides that are strongly recognized by PNA lectin (Fig 1, histogram [hist] 6), whereas parental CEM cells are almost nonreactive (Fig   1, hist 5 ). Further, it has been shown by others that HIVl + individuals make autoantibodies that bind to partially sialylated CD43 expressed on thymocytes, but not on peripheral blood lymphocytes of healthy or HIV-l+ individ~als.'~ Therefore, we were interested to look for a possible reactivity of HIV+ sera against CEMLAI/NP cells. As presented on Fig  1, the CEMLA[/NP cells were clearly stained by sera from HIV+ individuals (Fig 1, hist 2) by contrast with the very weak reactivity of parental CEM cells (Fig 1, hist l) , that is discussed below. Control sera from noninfected subjects did not recognize parental CEM or CEMLAI/NP cells (Fig 1, hist  2 and 3) . The results are summarized in Table 1 . Thus, all the randomized tested sera from asymptomatic HIV' individuals stained CEMLAINP cells, whereas 95.5% and 86.2% of the patients with ARC and AIDS, respectively, were reacting. Interestingly, all the sera tested from other autoimmune diseases such as systemic lupus erythematosus (six patients), rheumatoid arthritis (15 patients) and chronic hepatitis B (22 patients) were found to be nonreactive against CEMLAIDJP cells as did control sera from blood donors.
Autoantibodies to CEM,,/NP cells are predominantly IgM. To characterize the antibodies and to avoid problems caused by the interfering rheumatoid factor, IgG and IgM were fractionated by sucrose density ultracentrifugation be- reactive IgG were inconstant. When the two classes of Ig were detected, IgM were nearly always predominant (not shown).
Autoantibodies to CEM,,/NP cells do not recognize classic carbohydrate epitopes. We have shown that PNA lectin strongly binds CEMLAI/NP cells. Because (1) PNA reactivity appears when cryptic T-antigen (ie, nonsialylated Gal-GalNAc disaccharide) is unmaskedM and (2) all humans have anti-T antibodies:' we verified that the autoantibodies under study were not directed against a T-antigen. In fact, PNA lectin that binds the Gal-GalNAc disaccharide (or T-antigen) strongly stained CEMM/NP cells (Fig 1, hist 6 ), but did not interfere with autoantibodies (Fig 1, hist 7) . RCA 120 lectin, which binds terminal nonsialylated galactose48 (Gal), was also unable to deplete the autoantibodies reactivity (Fig 1,  hist 8) . Moreover, fetuin, asialofetuin, mucin, or asialomucin that bear numerous terminal sialylated and nonsialylated Gal-GalNAc and galactose-N-acetylglucosamine (GalGlcNAc) disaccharides were not able to deplete the autoantibodies reactivity (Fig 1, hist 9, 10, 11, and 12) . Finally, we verified that the autoantibodies were not eluted by galactose or lactose (Fig 1, hist 13 and 14) .
Autoantibodies precipitate mogly CD43. We have shown that metabolic sulforadiolabeling was a very useful tool for immunoprecipitation of CD43.= We used the rabbit serum LeukC prepared against the C-terminal intracellular domain of the molecule. The reactivity of this serum is not sialic aciddependent in contrast with most of the anti-CD43 MoAbs4' that have been screened for their reactivity against the sialic acid-rich extracellular domain.
As shown in Fig 3A, the Leukc antiserum was able to precipitate equally well the various sulforadiolabeled CD43 isoforms we recently describe~I,2~ ie, the 110-to 120-kD species from parental CEM cells (Fig 3A, lane 4) . the 135-to 160-kD heterogeneous species from latently-infected C E M u \ m cells (Fig 3A, lane  1) and the two different CD43 species from virus-producing CEMBa (Fig 3A, lane 2) and CEM, cells (Fig 3A, lane 3) .
Using this "SO?-metabolic incorporation, it was possible to show that Ig precipitated from all the sera of H I V + asymptomatic subjects were able to precipitate mogly CD43 molecules.
The same samples Ig were tested upon the lysates from CEMdNF' (Fig 3B) and CEMBa cells (Fig 3C) , respectively. With Ig from
individuals, precipitates were obtained with a Mr corresponding to the one described above (Fig 3,   B and C, lanes 4 through 12) , whereas control Ig from HIV- 
-
individuals did not (Fig 3, B and C, lanes 1 through 3) . All the HIV' sera recognized a broad 135-to 160-kD band ( Fig  3, B and C) . However, all of them recognized also a 1 IO-to 120-kD band that apparently corresponded to normal CD43 (Fig 3C) .
To characterize in more detail the immunoprecipitated molecules, specific CD43 depletions were performed on CEMLAI/NP cells lysates before immunoprecipitations with HIV' Ig. Results are shown in Fig 3D: three successive CD43 depletion rounds realized with the LeukC serum ( Fig  3D, rounds I, 2 , and 3 deposited in lanes 9.8, and 7, respectively) were able to completely abolish the reactivity of HIV+ Ig (Fig 3D, lane 6 ) that is presented in Fig 3D, lane 1. Using the anti-CD43 DF-TI MoAb, six depletion rounds were necessary (Fig 3D, rounds 1, 3 , and 6 deposited in lanes 13, 12, and 11, respectively) to obtain the same result shown in lane 10. As a control, the preimmune rabbit serum (Fig 3D,  depletion rounds I, 2 , and 3 deposited in lanes 5, 4, and 3, respectively) did not significantly deplete the HIV' Ig reactivity (Fig 3D, lane 2) .
To verify the Ig reactivity of HIV' individuals against the 1 IO-to 120-kD CD43, we next performed the same depletions test using sulforadiolabeled CEMscL cells lysates and obtained comparable results, ie, a total abolition of autoantibodies immunoprecipitates by the LeukC serum (not shown).
The 110-to 120-kD forms of CEM CD43 are partially hyposialylated. To better understand the Ig reactivity of HIV' individuals against the 110-to 120-kD CD43, we verified the sialylation status of these CD43 forms. Sulforadiolabeled CD43 was first immunoprecipitated from parental CEM and CEMLAJNP cells lysates by the LeukC serum, then eluted, and, thereafter, reincubated with immobilized SNA lectin that binds sialylated terminal Gal-GalNAcSo or PNA lectin that exhibits a high specificity for nonsialylated terminal Gal-GalNAc:* The results of CD43 sorting are shown on Fig 4. The total CD43 molecules immunoprecipitated from CEMLAI/NP and parental CEM cells were deposited on lanes 3 and 6, respectively. Sialylated SNA' CD43 sorted from CEM cells (Fig 4, lane 5 ) are predominant, in comparison with those from CEMLAJNP cells (Fig 4, lane  2) . As a consequence, the nonsialylated PNA' CD43 from CEMLAt/NP cells are largely predominant (Fig 4, lane 1) . However, it was possible to show a weak band of incompletely sialylated PNA' CD43 from parental CEM cells with Mr of 110 to 120 kD (Fig 4, lane 4) , especially if one takes into account loss of material during the succesive steps of the sorting experiments. These results are consistent with the very weak PNA reactivity towards parental CEM cells (Fig 1, hist 5) by contrast with the strong PNA binding to CEMLAJNP cells (Fig 1, hist 6) .
Sulforadiolabeled CD43 from PBMC lysates are not precipitated by HIV' sera. We verified a possible Ig reactivity of HIV' individuals sera against CD43 from PBMCs. Because these CD43 have been shown to also bear sulfate residues," the sensitive sulforadiolabeling assay was also very useful to visualize these molecules. The results are presented in Fig 5. Sulforadiolabeled CD43 from activated PBMC lysates was quantitatively estimated by three succesive rounds of precipitation by the LeukC serum (Fig 5,  lanes 1 through 3) . None of the five HIV+ Ig was able to precipitate CD43 from an equivalent amount of PBMC lysate (Fig 5, lanes 5 through 9) .
Autoantibodies to mogly CD43 do not cross-react with HIV-I antigens nor other cellular modified protein associated with HIV infection. Interference tests were performed using CD43-HIV-I -producing cells. A group of 293-CD4' and HeLa-CD4' cells (P4 clone) were infected with HIV-l LA1 strain. The infection rate was controlled to reach more than 80% of the cells, according to the the blue staining of infected P4 cells because the induction by Tat of the Lac Z expression driven by the HIV LTR. As shown in Fig 6, the sulforadiolabeled mogly CD43 precipitated by autoantibodies (Fig 6, lanes 1 and 2) can be exhausted by prior incubation with cold CEMLAI/NP cell lysates (Fig 6, lanes 3 and  4) , but not with mock-infected P4 or 293 cells (Fig 6, lanes For 
105 -5 and 6, and 9 and 10, respectively) and not with HIV-1-infected cells (Fig 6, lanes 7 and 8, and 11 and 12), thus showing the absence of cross-reactivity between autoantibodies antimogly CD43 and viral or cellular proteins associated with infected cells.
DISCUSSION
We have shown that the two major surface glycoproteins, CD43 and CD45 from the CEMLAJNP cells are partially ~ialylated?~.'~ We have also shown that in addition to its hyposialylation, the CD43 from CEMLAI/NP cells exhibits a more complex glycosylation pattern than the one from parental CEM cells. Indeed, the GalNAC moiety of its 0-glycans is differently substituted, and its important upward shift in SDS-PAGE cannot be totally explained by the reduction of its negative charges, owing to the hyp~sialylation.~' These alterations of glycosylation are observed on latently W-l-infected cells (CEM,,/NP), but also on virus-producing HIV+ cells (CEMsa. CEMLAI) that are chronically replicating the virus and simultaneously exhibit glycans alterations on various cellular glycoproteins for several months before becoming virus nonproducing At this stage, At the present time, the precise mechanism underlying the alterations of glycosylation we have described is not known. Because The extracellular domain of leukosialin has an extended, rod-like conformation, because its high content in carbohydrates (one 0-glycan unit per three amino acids in the extracellular domain of the molecule). It has been shown that the specificity of leukosialin epitopes is greatly dependent on glycosylation. In particular, the binding of MoAbs is differentially affected by the cell type and the removal of sialic acid. 53 Here we show that autoantibodies found in HIV' individuals, which have been shown to react against hyposialylated CD43 from thymocytes or from transfected COS cells?3 are able to bind more efficiently to the mogly CD43, obtained from HIV-l-infected CEM cells because, in our study, all the asymptomatic HIV+ subjects were found to be positive.
The weak reactivity of these sera directed against parental CEM cells is compatible with the findings reported by Ardman et al with the Sup-T1 T-cell line that is also recognized by a great proportion of the HIV+ sera.23 Indeed, hist l presented in Fig 1 corresponds to the reactivity of only 20% of the HIV' sera and cannot be compared with the one seen on HIV-l-infected CEM cells (Fig 1, hist 2) . We show that the percentage of HIV+ individuals synthesizing autoantibody anti-CEM,,,/NP cells decreases along the course of the desease from 100% at the asymptomatic stage to reach 86% at the AIDS stage. This evolution might be correlated with the one concerning the antibodies directed against structural HIV-1 antigens, of which the course curve is thought to be the reflection of the immunodeficiency progress a n d or the formation of immune complexes.54355 In this context, the soluble forms of CD4356 might be implicated.
The CD43 molecules, precipitated by HIV' sera from HIV-l-infected CEM cells lysates, correspond to (1) 135-to 160-kD forms shown to bear altered glycosylated side chains and expressed by latently infected CEMLAI/NP (Fig  3b) and virus-producing CEMBCL cells (Fig 3C) , and (2) 110-to 120-kD forms (Fig 3C) , of which the Mr apparently reflects a normal glycosylation. These CD43 forms expressed by parental CEM cells (Fig 3A, lane 4) and virus-producing CEMBCL cells (Fig 3A, lane 2) are likely to bear some nonsialylated terminal Gal-GalNAc moieties among the 70 to 85 0-linked carbohydrate side chains branched to each molecule (CD43 PNA' [Fig 4, lane 41) without apparent effect on the CD43 Mr, but are sufficient to trigger the HIV+ sera recognition. Then, the 110-to 120-kD CD43 precipitations by autoantibodies (Fig 3C) appears to be consistent with the faint PNA binding to the parental CEM cell surface (Fig 1,  hist 5 ) as well as the weak, but significant reactivity of some HIV+ sera towards these cells (Fig 1, hist 1) . Because CD43 molecules from activated PBMC lysates are not precipitated by HIV' sera (Fig 5) , CD43 PNA+ are unlikely expressed by these cells.
The autoantibodies reactivity towards mogly CD43 is unlikely to be directed against terminal nonsialylated Gal-GalNAc or Gal-GlcNAc moities for the following reasons: (1) PNA lectin that binds to Gal-GalNAc, and RC4120 lectin that binds to terminal Gal attached to GalNAc or GlcNAc, did not block the autoantibodies reactivity; (2) sialylated and nonsialylated glycoproteins such as fetuin, asialofetuin, mucin, or asialomucin, which bear numerous N-and 0-glycans did not interfere; and (3) CD45, which is also known to be sulfated25 and to be expressed with nonsialylated terminal 0-and N-linked Gal in the CEM,/NP and CEMBCL was not precipitated by autoantibodies in our study. Therefore, these autoantibodies antimogly CD43 might be directed against a conformational structure of the CD43 induced by altered glycosylation or against other carbohydrate moities implicated in the more complex arrangement of the 0-glycans on CD43 from HIV-l-infected cells. A conformational change of CD43 induced by hyposialylation appears as a more likely hypothesis because we observed that the removal of surface sialic acid residues from parental noninfected CEM cells by a mixture of sialidases enhanced the autoantibodies reactivity up to the one of CEMLArMP cells (not shown).
Autoantibodies antihyposialylated CD43 have been detected in up to 47% of HIV' individual^.'^ Our results indicating that these antibodies are found in all the infected subjects are probably caused by the use of (1) the metabolic 35S042-incorporation, which is a very sensitive assay for immunoprecipitation of CD43 molecule^^^ and (2) the CD43 species originating from latently HIV-1 -infected cells. These data are reminiscent of the observation that a defect in sialic acids is associated with rheumatoid arthritis. In this well-characterized autoimmune disease, asialylated IgG has been detected in serum and synovial fluid of patient^.^' Moreover, arthritic lesions similar to those seen in patients with RA have been observed after injection of homologous desialylated IgG into rabbit joints?8
Although the mogly CD43 responsible for the autoantibodies anti-CD43 synthesis has not been found in PBMC of HIV' individ~als,2~.*~ we have obtained preliminary results showing that 2% to 5% of lymphocytes in lymph nodes of HIV+ subjects are PNA+? 5 No direct evidence has been established that HIV-1 directly controls the altered glycosylation of CD43. However, these modified molecules seem to be associated with HIV-1 infection, owing to the autoantibodies synthesis found in every patient. For personal use only. on October 3, 2017. by guest www.bloodjournal.org From
